Illumina, Inc. (ILMN) has progressed in genomic research with the recent launch of DRAGEN v4.3. This is the latest version of the company’s DRAGEN software line. This new release marks a significant advancement in the field of next-generation sequencing (NGS), featuring an advanced multigenome mapping technology. This innovation allows for the inclusion of 128 samples from 26 different ancestries, thus capturing a broader spectrum of genetic diversity and reducing ancestry bias. The ability to create custom ...

(Photo Illustration by Igor Golovniov/SOPA Images/LightRocket via Getty Images) SOPA Images/LightRocket via Getty Images On June 3, 2024, Illumina’s (NASDAQ: ILMN, $109.82, Market Capitalization: $17.5 billion) board of directors approved the spin-off of its wholly owned subsidiary GRAIL, Inc. and shared the details on the timeline. Earlier on May 6, 2024, ILMN had filed the initial Form 10 disclosing the deal overview and separation agreement. Subsequently, on June 3, 2024, ILMN submitted an amended Form 1 ...

"We are excited to launch DRAGEN v4.3, with significant enhancements and additions to our analysis tools, empowering researchers and geneticists to maximize the value of the genome," said Rami Mehio, head of Software & Informatics at Illumina. "DRAGEN v4.3 includes our next-generation and most accurate multigenome mapping technology, built-in mosaic calling, advancements in machine learning, and the ability to genotype difficult genes to unlock deeper insights into the human genome with greater power, accur ...

Dublin, June 10, 2024 (GLOBE NEWSWIRE) -- The "Illumina Inc (ILMN) - Product Pipeline Analysis, 2024 Update" company profile has been added to ResearchAndMarkets.com's offering. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. ...

INDIA - 2023/12/16: In this photo illustration, the Illumina logo is seen displayed on a mobile ... [+] phone screen. (Photo Illustration by Idrees Abbas/SOPA Images/LightRocket via Getty Images) SOPA Images/LightRocket via Getty Images Illumina stock (NASDAQ: ILMN) saw a 7% rise on Thursday, June 6, faring better than its peer — Mettler- Toledo stock – down 1%. The rise in ILMN stock can primarily be attributed to the company’s decision to spin off its blood testing company – Grail. Illumina acquired Grail ...

文章核心观点 - 美国众议员Thomas Kean Jr.在4月进行了股票交易,买入了Illumina公司股票,卖出了耐克公司股票 [1] - Illumina公司是基因测序领域的领导者,该行业预计未来几年将保持高速增长 [6] - 耐克公司股价在今年前几个月表现较弱,可能是Kean卖出的原因 [5] Illumina公司 - Illumina公司CEO在2月份曾大量买入公司股票,这可能是Kean买入的原因 [3] - Illumina公司在2024年第一季度财报中表现强劲 [4] - Illumina公司所在的基因测序行业预计未来几年将以21.7%的复合年增长率快速增长 [6] 耐克公司 - 耐克公司股价在今年前几个月下跌12%,表现较弱,可能是Kean卖出的原因 [5] - 耐克公司目前股价相对于过去5年的平均水平有一定折价 [7]

Cunningham previously served as CCO for Exact Sciences and brings more than 20 years of commercial leadership across healthcare tech, life sciences, and pharma SAN DIEGO, June 3, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the appointment of Everett Cunningham as Chief Commercial Officer (CCO), effective June 10. Illumina, Inc., today announced the appointment of Everett Cunningham as Chief Commercial Officer, effective ...

Illumina, Inc. (NASDAQ:ILMN) Bernstein Strategic Decisions Conference May 29, 2024 9:00 AM ET Company Participants Ankur Dhingra - Chief Financial Officer Salli Schwartz - Vice President, Investor Relations Conference Call Participants Eve Burstein - Bernstein Research Eve Burstein Thanks so much for joining us. My name is Eve Burstein. I cover US life science, tools and diagnostics here at Bernstein. And I'm delighted to be joined by our Illumina friends. So Ankur Dhingra, CFO, Salli Schwartz, Head of IR. ...

SAN DIEGO, May 28, 2024 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today published its fifth annual Corporate Social Responsibility (CSR) Report. The report highlights the company's ongoing commitments and progress made in 2023 toward advancing human health by serving as a champion for patients, communities, employees, and the planet. Illumina released its 2023 CSR Report today, highlighting the company’s ongoing commitments and progress mad ...

Ms. Richo brings more than 30 years of regulated-industry experience as an attorney and legal executive, with extensive experience in compliance and business ethics, intellectual property, and corporate litigation. She formerly served as Corporate Senior Vice President, General Counsel, Chief Compliance Officer, and Corporate Secretary at Cargill, where she oversaw the company's corporate governance, global ethics and compliance, global security, global government relations, law, and shareholder relations f ...